Gupta, Neeraj http://orcid.org/0000-0002-5500-5218
Hanley, Michael J. http://orcid.org/0000-0001-9266-2797
Griffin, Robert J. http://orcid.org/0000-0002-1907-2421
Zhang, Pingkuan
Venkatakrishnan, Karthik http://orcid.org/0000-0003-4039-9813
Sinha, Vikram
Funding for this research was provided by:
Takeda Development Center Americas, Inc., Lexington, MA, USA.
Article History
Accepted: 26 June 2023
First Online: 26 July 2023
Declarations
:
: Professional medical writing assistance was funded by Takeda Development Center Americas, Inc., Lexington, MA, USA.
: Neeraj Gupta, Michael J. Hanley, Robert Griffin, and Pingkuan Zhang are employed with Takeda. Karthik Venkatakrishnan is employed with EMD Serono Research and Development Institute, Inc. and was employed with Takeda during the conduct of the research reviewed in this article. Vikram Sinha is employed with Novartis Development Corporation and was employed with Takeda during article development.
: Ethics approval was not required for this review.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: NG: conceived the article concept; drafted, critically revised, and approved the manuscript. MJH: performed the data analysis; drafted, critically revised, and approved the manuscript. RG: provided nonclinical absorption, distribution, metabolism, and excretion/drug–drug interaction data, helped author the related sections, and reviewed and approved the manuscript. PZ: critically revised and approved the manuscript. KV: critically revised and approved the manuscript. VS: critically reviewed and approved the manuscript.